{"organizations": [], "uuid": "9a057e1eb7c445bb5759a3c7eda0a2eedad26576", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180226.html", "section_title": "Archive News &amp; Video for Monday, 26 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-genomic-health-expands-offering-to/brief-genomic-health-expands-offering-to-prostate-cancer-patients-with-launch-of-oncotype-dx-ar-v7-nucleus-detect-test-to-predict-treatment-response-in-metastatic-disease-idUSFWN1QG109", "country": "US", "domain_rank": 408, "title": "BRIEF-Genomic Health Expands Offering To Prostate Cancer Patients With Launch Of Oncotype DX AR-V7 Nucleus Detect Test To Predict Treatment Response In Metastatic Disease", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.777, "site_type": "news", "published": "2018-02-26T21:12:00.000+02:00", "replies_count": 0, "uuid": "9a057e1eb7c445bb5759a3c7eda0a2eedad26576"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-genomic-health-expands-offering-to/brief-genomic-health-expands-offering-to-prostate-cancer-patients-with-launch-of-oncotype-dx-ar-v7-nucleus-detect-test-to-predict-treatment-response-in-metastatic-disease-idUSFWN1QG109", "ord_in_thread": 0, "title": "BRIEF-Genomic Health Expands Offering To Prostate Cancer Patients With Launch Of Oncotype DX AR-V7 Nucleus Detect Test To Predict Treatment Response In Metastatic Disease", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - genomic health inc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 26 (Reuters) - Genomic Health Inc:\n* GENOMIC HEALTH EXPANDS OFFERING TO PROSTATE CANCER PATIENTS WITH LAUNCH OF ONCOTYPE DX® AR-V7 NUCLEUS DETECT™ TEST TO PREDICT TREATMENT RESPONSE IN METASTATIC DISEASE Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-26T21:12:00.000+02:00", "crawled": "2018-02-27T15:05:26.038+02:00", "highlightTitle": ""}